Publications by authors named "H Nagaoka"

Wheat bran (WB) is a low-value by-product of the wheat milling industry. Solid-state fermentation with is performed to improve WB's nutritional quality (RH). Twenty-five mice (11-week-old C57BL/6N male mice) were divided into three groups.

View Article and Find Full Text PDF

RHOV and RHOU are considered atypical Rho-family small GTPases because of the existence of N- and C-terminal extension regions, abnormal GDP/GTP cycling, and post-translational modification. Particularly, RHOV and RHOU both have a proline-rich (PR) motif in the N-terminal region. It has been reported that the PR motif of RHOU interacts with GRB2, a SH3 domain-containing adaptor protein, and regulates its activity through EGF receptor signaling.

View Article and Find Full Text PDF

Many infections, including malaria, are associated with an increase in autoantibodies (AAbs). Prior studies have reported an association between genetic markers of susceptibility to autoimmune disease and resistance to malaria, but the underlying mechanisms are unclear. Here, we performed a longitudinal study of children and adults (n = 602) in Mali and found that high levels of plasma AAbs before the malaria season independently predicted a reduced risk of clinical malaria in children during the ensuing malaria season.

View Article and Find Full Text PDF

Interferon regulatory factor 4 (IRF4) is a crucial transcription factor that plays a vital role in lymphocyte development, including in the fate-determining steps in terminal differentiation. It is also implicated in the development of lymphoid tumors such as multiple myeloma and adult T-cell leukemia. IRF4 can form a homodimer and multiple heterocomplexes with other transcription factors such as purine-rich box1 and activator protein 1.

View Article and Find Full Text PDF
Article Synopsis
  • Extensive efforts have reduced malaria cases significantly in the past 20 years, but progress has stalled recently, especially due to the COVID-19 pandemic.
  • The WHO has recommended the use of the RTS,S/AS01 vaccine for children in malaria-prone regions and recently endorsed another vaccine, R21/Matrix-M, on October 3, 2023.
  • There is a need for better asexual blood-stage malaria vaccines, as current candidates face challenges like antigen diversity and low immune responses, highlighting the urgency for new vaccine innovations.
View Article and Find Full Text PDF